Leading with strategy, our RCO model delivers bespoke / custom solutions that deliver results. Our fit-for purpose global solutions span across the full product lifecycle.
Learn more about our RCO model.
Explore all RCO Solutions
Explore all Services
Explore all Therapeutic Areas
Insight & News
June 17, 2014
CEO Matthew Weinberg writes for Tobacco Reporter Magazine encouraging stakeholders to take advantage of the opportunity to respond to FDA e-cigarette regulations.
April 23, 2012
April 23 - The Weinberg Group CEO, Matthew Weinberg, presented today at FDA’s hearing titled “Modernizing the Regulation of Clinical Trials and Approaches to Good Clinical Practice.” Mr. Weinberg...
February 11, 2014
For more information on The Weinberg Group’s independent clinical auditing services, please contact Jeff Antos at firstname.lastname@example.org or 202.280.0815.
November 25, 2014
FDANews Drug Industry Daily Nov. 21, 2014 Europe’s drug regulatory agency has revised the conflict of interest policy for its scientific committee members and experts, a move that one attorney says...